Defective recombination-activating gene (RAG) expression may contribute development of autoantibodies in patients with systemic lupus erythematosus (SLE).

被引：0
|
作者：
Nagafuchi, H [1 ]
Suzuki, N [1 ]
Sakane, T [1 ]
机构：
[1] St Marianna Univ, Sch Med, Kawasaki, Kanagawa 2168512, Japan
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
232
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [31] Altered lipid metabolism contributes to defective iNKT-cell function in patients with systemic lupus erythematosus (SLE)
    Smith, E. C.
    El Bardisy, S.
    Torra, I. Pineda
    Isenberg, D. A.
    Jury, E. C.
    IMMUNOLOGY, 2014, 143 : 51 - 51
  • [32] Evaluation of the polymorphism of IL-1RN gene in patients with SLE (systemic lupus erythematosus)
    Ganjali, Rashin
    Afshari, Jalil Tavakkol
    Mazhani, Maryarn
    CLINICAL IMMUNOLOGY, 2007, 123 : S89 - S89
  • [33] Vasculitis in patients with systemic lupus erythematosus:: Classification and impact on the clinical and immunological expression of SLE.
    Ramos-Casals, M
    Nardi, N
    Lagrutta, M
    Brito-Zerón, P
    Bové, A
    Delgado, G
    Cervera, R
    Ingelmo, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S190 - S190
  • [34] DEVELOPMENT OF A DNA-ADSORBENT FOR THE SPECIFIC REMOVAL OF ANTI-DNA AUTOANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    HIEPE, F
    WOLBART, K
    SCHOSSLER, W
    SPEER, A
    MONTAG, T
    MIELKE, F
    APOSTOLOFF, E
    BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1990, 18 (05): : 683 - 688
  • [35] THE EXPRESSION OF MICROPARTICLES IN THE BLOOD OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): PHENOTYPIC CHARACTERIZATION AND CLINICAL ASSOCIATIONS
    Mobarrez, F.
    Vikerfors, A.
    Gustafsson, J.
    Gunnarsson, I.
    Zickert, A.
    Larsson, A.
    Pisetsky, D.
    Wallen, H.
    Svenungsson, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S70 - S70
  • [36] DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Jolly, M.
    Kosinski, M.
    Garris, C. P.
    Jhingran, P. M.
    Mikolaitis, R. A.
    Dennis, G.
    Wallace, D. J.
    Clarke, A.
    Parke, A.
    Dooley, M. A.
    Strand, V
    Alarcon, G. S.
    VALUE IN HEALTH, 2011, 14 (03) : A65 - A66
  • [37] Measurement of disease activity in systemic lupus erythematosus (SLE) using microarray gene expression analysis.
    Nikpour, M
    Dempsey, A
    Urowitz, V
    Gladman, D
    Barnes, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4055 - 4055
  • [38] A LOW DENSITY GRANULOCYTE GENE EXPRESSION SIGNATURE DISTINGUISHES BETWEEN ACTIVE PATIENTS WITH AND WITHOUT NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Wither, J.
    Prokopec, S.
    Noamani, B.
    Bonilla, D.
    Touma, Z.
    Reich, H.
    Scholey, J.
    Fortin, P.
    Boutros, P.
    Landolt-Marticorena, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 103 - 103
  • [39] Prevalence of carotid atherosclerosis in children patients with systemic lupus erythematosus (SLE): Association with autoantibodies and other risk factors.
    Pinochet, C
    Gutierrez, MA
    Mertens, R
    Cisternas, M
    Rivera, D
    Tagle, R
    Mezzano, V
    Jacobelli, S
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S148 - S148
  • [40] Linkage and interaction of loci on 1q23 and IBD1 may contribute to susceptibility to systemic lupus erythematosus (SLE).
    Tsao, BP
    Grossman, JM
    Kim, SK
    Wallace, DJ
    Chen, CJ
    Lau, CS
    Ginzler, EM
    Goldstein, R
    Shen, N
    Kalunian, KC
    Arnett, FC
    Hahn, BH
    Cantor, RM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 527 - 527
12345